INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 41 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,522,000 | +10.2% | 5,044,000 | 0.0% | 0.00% | – |
| Q1 2021 | $4,105,000 | -53.6% | 5,044,000 | -56.0% | 0.00% | -100.0% |
| Q4 2020 | $8,842,000 | -4.1% | 11,469,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,220,000 | +3216.5% | 11,469,000 | +3008.1% | 0.00% | – |
| Q2 2020 | $278,000 | -86.2% | 369,000 | -85.4% | 0.00% | – |
| Q1 2020 | $2,015,000 | -20.7% | 2,519,000 | 0.0% | 0.00% | – |
| Q4 2019 | $2,540,000 | +17.3% | 2,519,000 | 0.0% | 0.00% | – |
| Q3 2019 | $2,166,000 | -3.6% | 2,519,000 | 0.0% | 0.00% | – |
| Q2 2019 | $2,246,000 | +1101.1% | 2,519,000 | +1232.8% | 0.00% | – |
| Q1 2019 | $187,000 | – | 189,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|